Research Output per year
Fingerprint Dive into the research topics where Pietro Bulian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
B-Cell Chronic Lymphocytic Leukemia
Medicine & Life Sciences
Interleukin-2 Receptors
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Large Granular Lymphocytic Leukemia
Medicine & Life Sciences
Reticulocytes
Medicine & Life Sciences
Flow Cytometry
Medicine & Life Sciences
Lymphocytes
Chemical Compounds
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1988 2018
8
Citations
(Scopus)
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
Tissino, E., Benedetti, D., Herman, S. E. M., ten Hacken, E., Ahn, I. E., Chaffee, K. G., Rossi, F. M., Bo, M. D., Bulian, P., Bomben, R., Bayer, E., Härzschel, A., Gutjahr, J. C., Postorino, M., Santinelli, E., Ayed, A., Zaja, F., Chiarenza, A., Pozzato, G., Chigaev, A. & 9 others, , Feb 1 2018, In : Journal of Experimental Medicine. 215, 2, p. 681-697 17 p.Research output: Contribution to journal › Article
Integrin alpha4beta1
B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Lymphocytosis
Integrins
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases
Mazzaro, C., Maso, L. D., Mauro, E., Gattei, V., Ghersetti, M., Bulian, P., Moratelli, G., Grassi, G., Zorat, F. & Pozzato, G., May 3 2018, In : Rare Diseases. 6, 2Research output: Contribution to journal › Article
Cryoglobulinemia
Survival
Purpura
Ribavirin
Alkylating Agents
Low-dose radiotherapy in diffuse large B-cell lymphoma
Furlan, C., Canzonieri, V., Spina, M., Michieli, M., Ermacora, A., Maestro, R., Piccinin, S., Bomben, R., Dal Bo, M., Trovo, M., Gattei, V., Tirelli, U., Franchin, G. & Bulian, P., 2017, In : Hematological Oncology. 35, 4, p. 472-479 8 p.Research output: Contribution to journal › Article
Lymphoma, Large B-Cell, Diffuse
Radiotherapy
B-Lymphocytes
Germinal Center
Quality of Life
4
Citations
(Scopus)
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia
Bulian, P., Bomben, R., Bo, M. D., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D'Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D'Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, , Nov 2017, In : Haematologica. 102, 11, p. e443-e446Research output: Contribution to journal › Article
4
Citations
(Scopus)
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia
Bulian, P., Bomben, R., Dal Bo, M., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D’Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D’Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, , Oct 27 2017, In : Haematologica. 102, 11, p. e443-e446Research output: Contribution to journal › Letter